221 results on '"Sezen, Duygu"'
Search Results
2. Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
3. Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
4. NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
5. Mechanisms of Action of Radiotherapy and Immunotherapy in Lung Cancer: Implications for Clinical Practice
6. Preoperative Radiosurgical Management of Brain Metastases: Evidence and Challenges
7. Combined Stereotactic Radiosurgery and Immune Checkpoint Inhibitors for the Treatment of Brain Metastasis
8. Esophageal cancer
9. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease
10. Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
11. FAST- Forward Radiotherapy in Breast Cancer Patients from a Turkish Cohort: A Study on Acute Skin Toxicity.
12. Mechanisms of Action of Radiotherapy and Immunotherapy in Lung Cancer: Implications for Clinical Practice
13. Toxicity Management for Pelvic Tumors in Radiation Oncology
14. A Review on Brain Metastases Prognostic Scoring Systems
15. Lymphoma
16. Breast Cancer
17. Lung Cancer
18. Head and Neck Cancers
19. A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model
20. Stereotactic Radiosurgery Techniques and Quality Assurance for Brain Metastases
21. Management of Brain Metastases with Preoperative Radiosurgery
22. A Comprehensive Review on Tumor Cavity Stereotactic Radiosurgery for Resected Brain Metastases
23. Prostate Cancer Risk Grouping and Selection Criteria Based on Radiation Oncology Perspective
24. Impact of Prolonged Neoadjuvant Treatment–surgery Interval on Histopathologic and Operative Outcomes in Patients Undergoing Total Mesorectal Excision for Locally Advanced Rectal Cancer
25. Supplementary Figures and Tables from Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer
26. Data from Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer
27. Modern Radiotherapy Techniques in Lung Cancer
28. Selection Criteria for Definitive Treatment Approach in Thoracic Malignancies: Radiation Oncology Perspective
29. Contributors
30. Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and Retention
31. NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
32. Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD1 in Metastatic Non-Small Cell Lung Cancer
33. In Regard to Hammer et al.
34. Systemic Inflammation Score for Predicting Radiation-Induced Trismus and Osteoradionecrosis of the Jaw Rates in Locally Advanced Nasopharyngeal Carcinoma Patients.
35. Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
36. In Regard to Shee et al
37. Combining a nanoparticle-mediated radioimmunotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
38. Additional file 2 of Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
39. Additional file 1 of Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
40. Design Considerations for Clinical Trials of Radiotherapy Combined with Immunotherapy.
41. Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers
42. High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses
43. Painful plantar heel spur treatment with Co-60 teletherapy: factors influencing treatment outcome
44. 575 Dual blockade of LAG3 and TIGIT improves the treatment efficacy of a nanoparticle-mediated immunoradiation in anti-PD1 resistant lung cancer in mice
45. Hypofractionated radiation therapy (HFRT) of breast/chest wall and regional nodes in locally advanced breast cancer: Toxicity profile and survival outcomes in retrospective mono-institutional study: In regard to De Matteis et al.
46. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma
47. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
48. The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
49. Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer
50. Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.